Gavi Signs Agreement with Bavarian Nordic to Rapidly Secure 500,000 Doses of Mpox Vaccines for Africa
The advance purchase agreement (APA) will be funded by Gavi’s First Response Fund, a mechanism created after the COVID-1…
The advance purchase agreement (APA) will be funded by Gavi’s First Response Fund, a mechanism created after the COVID-1…
First mpox vaccine to obtain prequalification by the WHO Approval will help accelerate access to the vaccine for all…
PNO and Trailer Dynamics are excited to announce a strategic partnership. Together, the two companies are launching a gr…
Vaccine donations from the European Commission, the U.S. government and Bavarian Nordic are now entering the DRC, the ep…
Bavarian Nordic A/S (OMX: BAVA) announced today that Singapore’s medicines regulatory authority, Health Sciences Authori…
Bavarian Nordic A/S (OMX: BAVA) provides an update on plans for securing supply of vaccines to tackle the current mpox o…
Interim results from clinical study show non-inferiority of immune responses from mpox/smallpox vaccination in adolescen…
Bavarian Nordic A/S (OMX: BAVA) announced today a new order from HERA (the European Health Emergency Preparedness and Re…
Bavarian Nordic A/S (OMX: BAVA) today announced that the U.S. Food and Drug Administration (FDA) has accepted and grante…
We are delighted to announce the appointment of our colleague Dr Stefanie Weidner to the Executive Board of Werner Sobek…